在COVID-19相关的嗅觉功能障碍患者中,嗅觉训练和全身维生素A的治疗效果:双盲随机对照临床试验
Abolfazl Taheri1, Maryam Naderi2, Nematollah Jonaidi Jafari3
1New Hearing Technologies Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran; Department of Otorhinolaryngology Head and Neck Surgery, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Brazilian journal of otorhinolaryngology
|July 7, 2024
概括
嗅觉训练有效地改善了COVID-19患者的嗅觉损失. 添加维生素A并没有提高这些结果,但仅仅嗅觉训练在12个月内就显示出显著的嗅觉恢复.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 传染性疾病 传染性疾病
- 神经学 神经学
背景情况:
- COVID-19呈现出各种症状,包括嗅觉功能障碍.
- 嗅觉丧失 (无味症) 是COVID-19的一个常见和令人痛苦的症状.
研究的目的:
- 评估嗅觉训练对COVID-19相关的嗅觉功能障碍的有效性.
- 研究口服维生素A与嗅觉训练相结合的额外益处.
主要方法:
- 一项随机临床试验,涉及90名COVID-19相关的嗅觉功能障碍患者.
- 三组:仅嗅觉训练,用维生素A进行嗅觉训练,以及鼻水灌 (对照).
- 在干预前,干预后 (3个月) 和12个月的随访期间,使用了标准化气味测试和厌氧气体报告工具.
主要成果:
- 与对照组 (C) 相比,在两个嗅觉训练组 (A和B) 中都观察到嗅觉功能的显著改善.
- 组A (嗅觉训练) 显示76.9%的改善;组B (嗅觉训练+维生素A) 显示86.7%的改善.
- 与单独的嗅觉训练相比,添加维生素A并没有产生统计学上优异的结果.
结论:
- 三个月的嗅觉训练是一种可行的,有效的治疗COVID-19引起的嗅觉功能障碍.
- 口服维生素A补充剂似乎没有增强嗅觉训练对嗅觉恢复的益处.
相关概念视频
Physiology of Smell and Olfactory Pathway
8.3K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
8.3K
Acute Respiratory Failure-V
129
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
129
COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
Asthma: Pathogenesis and Management
381
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
381
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Drugs Used in Upper Respiratory Disorders: Overview
209
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
209


